Anti-Adalimumab Antibodies Purified from Juvenile Idiopathic Arthritis Patients: Kinetic Characterization Among Biosimilars

The use of adalimumab biosimilars has become increasingly common in clinical practice, reflecting their growing acceptance and efficacy as therapeutic alternatives to reference biologics. However, studies investigating the molecular interactions between anti-adalimumab antibodies (AAA) elicited in p...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrea Di Santo, Edoardo Marrani, Carmen Gallo, Fosca Errante, Valerio Maniscalco, Anna Maria Papini, Gabriele Simonini, Paolo Rovero, Feliciana Real Fernandez
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Biosensors
Subjects:
Online Access:https://www.mdpi.com/2079-6374/15/5/278
Tags: Add Tag
No Tags, Be the first to tag this record!